Because of strong evidence for such side-effects, they are described in patient leaflets as very common although manufacturers note they usually go away over time
Nutritional considerations are particularly relevant
Such insights not only advance our understanding of BTBD19s role in colorectal oncogenesis but also highlight actionable pathways for therapeutic intervention, guiding future studies to explore BTBD19 as a potential biomarker or therapeutic target in CRC
For management strategies, see our semaglutide side effects guide
doi:10.1176/appi.ajp.163.1.28CrossRefGoogle ScholarPubMed Veronese, N., Stubbs, B., Solmi, M., Ajnakina, O., Carvalho, A